Effects of Extra-Fine Inhaled and Oral Corticosteroids on Alveolar Nitric Oxide in COPD
- 22 February 2012
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 190 (4) , 395-401
Abstract
Alveolar nitric oxide (CANO) has been suggested as a surrogate marker of distal airway inflammation in COPD. Coarse particle-inhaled corticosteroids (ICS) have been shown not to suppress CANO. We evaluated whether extra-fine particle size ICS (HFA-BDP) or systemic oral corticosteroids could suppress CANO in COPD. Chronic obstructive pulmonary disease (COPD) patients with a FEV1/FVC ratio NO was corrected for axial diffusion. In 16 participants, there were no significant differences seen with either dose of HFA-BDP compared with placebo. Oral prednisolone significantly reduced FENO and J’awNO but not CANO. Plasma cortisol was significantly suppressed by oral prednisolone only. Whilst CANO remains a biomarker of interest in COPD, it is not suppressed by systemic or extra-fine particle ICS. CANO is not a useful marker for monitoring response of small airway disease to therapies in COPD. The study was approved by the local Committee on Medical Research Ethics and registered on ClinicalTrials.Gov (NCT 00921921).Keywords
This publication has 26 references indexed in Scilit:
- Paradoxical Trough Effects of Triple Therapy With Budesonide/Formoterol and Tiotropium Bromide on Pulmonary Function Outcomes in COPDChest, 2010
- Central and Peripheral Airway Sites of Nitric Oxide Gas Exchange in COPDChest, 2010
- Differential Flow Analysis of Exhaled Nitric Oxide in Patients With Asthma of Differing SeverityChest, 2007
- Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthmaEuropean Respiratory Journal, 2005
- Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic AsthmaNew England Journal of Medicine, 2005
- Exhaled Nitric Oxide and Hydrogen Peroxide in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ, 2000
- Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 1999
- A two-compartment model of pulmonary nitric oxide exchange dynamicsJournal of Applied Physiology, 1998